Mifepristone
Drug
GenBioPro, Inc.
Total Payments
$269,065
Transactions
17
Doctors
10
Companies
1
Payment Trends by Year
| Year | Amount | Transactions | Doctors |
|---|---|---|---|
| 2024 | $49,471 | 2 | 2 |
| 2023 | $108,618 | 8 | 8 |
| 2022 | $39,050 | 2 | 2 |
| 2021 | $36,951 | 3 | 3 |
| 2020 | $34,975 | 2 | 2 |
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Consulting Fee | $161,947 | 10 | 60.2% |
| Unspecified | $107,118 | 7 | 39.8% |
Payments by Type
General
$161,947
10 transactions
Research
$107,118
7 transactions
Research Studies & Clinical Trials
| Study Name | Sponsor | Amount | Doctors |
|---|---|---|---|
| MERMAID Study | GenBioPro, Inc. | $107,118 | 7 |
Top Doctors Receiving Payments for Mifepristone
| Doctor | Specialty | Location | Total | Records |
|---|---|---|---|---|
| , M.D | Gynecology | Phoenix, AZ | $142,947 | 4 |
| , MD | Obstetrics & Gynecology | Cleveland, OH | $30,800 | 1 |
| , M.D | Obstetrics & Gynecology | Charleston, SC | $20,977 | 1 |
| , MD | Specialist | Washington, DC | $17,600 | 5 |
| , MD FAC OG | Obstetrics & Gynecology | Gulfport, MS | $14,000 | 1 |
| , M.D | Obstetrics & Gynecology | Hastings, NE | $14,000 | 1 |
| , M.D | Maternal & Fetal Medicine | San Diego, CA | $9,500 | 1 |
| , M.D | Obstetrics & Gynecology | New Bern, NC | $9,500 | 1 |
| , M.D | Obstetrics & Gynecology | Norfolk, VA | $8,341 | 1 |
| , M.D | Obstetrics & Gynecology | Lost Angeles, CA | $1,400 | 1 |
Ad
Manufacturing Companies
- GenBioPro, Inc. $269,065
Product Information
- Type Drug
- Total Payments $269,065
- Total Doctors 10
- Transactions 17
About Mifepristone
Mifepristone is a drug associated with $269,065 in payments to 10 healthcare providers, recorded across 17 transactions in the CMS Open Payments database. The primary manufacturer is GenBioPro, Inc..
Payment data is available from 2020 to 2024. In 2024, $49,471 was paid across 2 transactions to 2 doctors.
The most common payment nature for Mifepristone is "Consulting Fee" ($161,947, 60.2% of total).
Mifepristone is associated with 1 research study, including "MERMAID Study" ($107,118).